Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial
- 26 June 2008
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 23 (7), 814-825
- https://doi.org/10.1177/0269881108091595
Abstract
The objective of this study was to identify mechanisms through which valproic acid (VPA) causes weight gain. Healthy participants ( N = 52) were randomized to VPA or placebo in a double-blind study. Energy intake (EI) was measured in the laboratory at lunch and dinner, and physical activity (PA) was measured with accelerometry. Glucose levels and hormones [Peptide YY3–36, glucagon-like peptide-1 (GLP-1), leptin, ghrelin, insulin] that regulate EI were measured. Assessments occurred at baseline and week 3. Change from baseline was evaluated with mixed models (α = 0.05). Weight significantly increased in the VPA group (+0.49 kg), but not the placebo group. The VPA group increased fast food fats cravings and decreased glucose levels compared with placebo. Change in weight, EI and PA did not differ by group. Within group analyses indicated that the VPA group increased PA, hunger, binge eating, depression and GLP-1. VPA-associated weight gain is not likely due to changes in PA or the gut hormones studied. Although EI did not increase when measured after 3 weeks of treatment, VPA decreased glucose levels and increased motivation to eat; hence, EI might have increased in the short-term. Research testing VPA on short-term (1 week) EI, metabolism, and substrate partitioning is warranted.Keywords
This publication has 41 references indexed in Scilit:
- How Accurate Is Self-Reported Dietary Energy Intake?Nutrition Reviews, 2009
- Interactions between the “cognitive” and “metabolic” brain in the control of food intakePhysiology & Behavior, 2007
- The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesityExpert Opinion on Investigational Drugs, 2005
- Valproate in bipolar disorder: 2000 onwardsActa Psychiatrica Scandinavica, 2005
- Gastrointestinal Satiety Signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptideAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36The New England Journal of Medicine, 2003
- Molecular pathways to obesityInternational Journal of Obesity, 2002
- Role of Nonexercise Activity Thermogenesis in Resistance to Fat Gain in HumansScience, 1999
- Original Articles Sibutramine Reduces Food Intake in Non‐Dieting Women with ObesityObesity Research, 1998
- The Association of Body Weight, Dietary Intake, and Energy Expenditure with Dietary Restraint and DisinhibitionObesity Research, 1995